An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity

References

• Brynestad S, Granum PE. Clostridium perfringens and foodborne infections. Int J Food Microbiol. 2002;74:195–202.
   PubMed Web of Science ®Google Scholar
• Uzal FA. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. Anaerobe. 2004;10:135–143.
   PubMed Web of Science ®Google Scholar
• Rood JI. Virulence genes of Clostridium perfringens. Annu Rev Microbiol. 1998;52:333–360.
   PubMed Web of Science ®Google Scholar
• Rood JI, Adams V, Lacey J, et al. Expansion of the Clostridium perfringens toxin-based typing scheme. Anaerobe. 2018;53:5–10.
   PubMed Web of Science ®Google Scholar
• Ochi S, Oda M, Matsuda H, et al. Clostridium perfringens α-toxin activates the sphingomyelin metabolism system in sheep erythrocytes. J Biol Chem. 2004;279:12181.
   PubMed Web of Science ®Google Scholar
• Wang D, Yue Y, Wu G, et al. Preparation and characterization of a human scfv against the Clostridium perfringens type A alpha-toxin. Toxicon. 2017;130:79–86.
   PubMed Web of Science ®Google Scholar
• Ninomiya M, Matsushita O, Minami J, et al. Role of alpha-toxin in Clostridium perfringens infection determined by using recombinants of C. perfringens and Bacillus subtilis. Infect Immun. 1994;62:5032.
   PubMed Web of Science ®Google Scholar
• Sakurai J, Nagahama M, Oda M. Clostridium perfringens alpha-toxin: characterization and mode of action. J Biochem. 2004;136:569–574.
   PubMed Web of Science ®Google Scholar
• Popescu F, Wyder M, Gurtner C, et al. Susceptibility of primary human endothelial cells to C. perfringens beta-toxin suggesting similar pathogenesis in human and porcine necrotizing enteritis. Vet Microbiol. 2011;153:173–177.
   PubMed Web of Science ®Google Scholar
• Seike S, Takehara M, Kobayashi K, et al. Role of pannexin 1 in Clostridium perfringens beta-toxin-caused cell death. Biochim Biophys Acta. 2016;1858:3150–3156.
   PubMed Web of Science ®Google Scholar
• Herholz C, Miserez R, Nicolet J, et al. Prevalence of β2-toxigenic Clostridium perfringens in horses with intestinal disorders. J Clin Microbiol. 1999;37:358–361.
   PubMed Web of Science ®Google Scholar
• Hazlett MJ, Kircanski J, Slavic D, et al. Beta 2 toxigenic Clostridium perfringens type A colitis in a three-day-old foal. J Vet Diagn Invest. 2011;23:373–376.
   PubMed Web of Science ®Google Scholar
• Rumah KR, Ma Y, Linden JR, et al. The myelin and lymphocyte protein MAL is required for binding and activity of Clostridium perfringens ε-Toxin. PLoS Pathog. 2015;11:e1004896.
   PubMed Web of Science ®Google Scholar
• Bielen A, Šimatović A, Kosić-Vukšić J, et al. Negative environmental impacts of antibiotic-contaminated effluents from pharmaceutical industries. Water Res. 2017;126:79–87.
   PubMed Web of Science ®Google Scholar
• Siqueira FF, Silva ROS, Do Carmo AO, et al. Immunization with a nontoxic naturally occurring Clostridium perfringens alpha toxin induces neutralizing antibodies in rabbits. Anaerobe. 2017;49:48–52.
   PubMed Web of Science ®Google Scholar
• Makarova KS, Koonin EV. Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci USA. 2006;103:15611–15616.
   PubMed Web of Science ®Google Scholar
• Lebeer S, Claes I, Tytgat HLP, et al. Functional analysis of Lactobacillus rhamnosus GG Pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl Environ Microbiol. 2012;78:185–193.
   PubMed Web of Science ®Google Scholar
• Johnson-Henry KC, Donato KA, Shen-Tu G, et al. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157: H7-inducedchanges in epithelial barrier function. Infect Immun. 2008;76:1340–1348.
   PubMed Web of Science ®Google Scholar
• Yang GY, Jiao Y, Su JH, et al. Oral administration of Lactobacillus rhamnosus GG ameliorates Salmonella infantis-induced inflammation in a pig model via activation of the il-22bp/il-22/stat3 pathway. Front Cell Infect Microbiol. 2017;7:323.
   PubMed Web of Science ®Google Scholar
• Albarracin L, Kobayashi H, Iida H, et al. Transcriptomic analysis of the innate antiviral immune response in porcine intestinal epithelial cells: influence of immunobiotic lactobacilli. Front Immunol. 2017;8:57.
   PubMed Web of Science ®Google Scholar
• Wang PP, Li Y, Xiao H, et al. Isolation of Lactobacillus reuteri from Peyer’s patches and their effects on sIgA production and gut microbiota diversity. Mol Nutr Food Res. 2016;60:2020–2030.
   PubMed Web of Science ®Google Scholar
• Mohamadzadeh M, Olson S, Kalina WV, et al. Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci USA. 2005;102:2880–2885.
   PubMed Web of Science ®Google Scholar
• Cervantes-Barragan L, Chai JN, Tianero MD, et al. Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells. Science. 2017;357:806.
   PubMed Web of Science ®Google Scholar
• Alander M, Satokari R, Korpela R, et al. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Appl Environ Microbiol. 1999;65:351–354.
   PubMed Web of Science ®Google Scholar
• Xu YG, Cui LC, Tian CY, et al. Immunogenicity of recombinant classic swine fever virus CD8+T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination. Clin Vaccine Immunol. 2011;18:1979–1986.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Y. Induction of immune responses after intragastric administration of mice with lactobacillus casei producing porcine parvovirus protective antigen VP2 protein. Appl Environ Microbiol. 2007;73:7041–7047.
   PubMed Web of Science ®Google Scholar
• Wang M, Pan L, Zhou P, et al. Protection against foot-and-mouth disease virus in Guinea pigs via oral administration of recombinant Lactobacillus plantarum expressing VP1. Plos One. 2015;10:e0143750.
   PubMed Web of Science ®Google Scholar
• Xu YG, Guan XT, Liu ZM, et al. Immunogenicity of recombinant Lactobacillus plantarum expressing classical swine fever virus E2 protein in conjunction with thymosin α-1 as an adjuvant in swine via oral administration. Appl Environ Microbiol. 2015;81:3745–3752.
   PubMed Web of Science ®Google Scholar
• Wang Y, Feng B, Niu C, et al. Dendritic cell targeting of bovine viral diarrhea virus E2 protein expressed by Lactobacillus casei effectively induces antigen-specific immune responses via oral vaccination. Viruses. 2019;11:575.
   PubMed Web of Science ®Google Scholar
• Yu M, Wang L, Ma S, et al. Immunogenicity of eGFP-marked recombinant Lactobacillus casei against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Viruses. 2017;9:274.
   Web of Science ®Google Scholar
• Ma S, Wang L, Huang X, et al. Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus. Microb Cell Fact. 2018;17:20.
   PubMed Web of Science ®Google Scholar
• Gao X, Ma Y, Wang Z, et al. Oral immunization of mice with a probiotic Lactobacillus casei constitutively expressing the α-toxoid induces protective immunity against Clostridium perfringens α-toxin. Virulence. 2019;10:166–179.
   PubMed Web of Science ®Google Scholar
• Zhao L, Guo Z, Liu J, et al. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits. Vaccine. 2017;35:4010–4021.
   PubMed Web of Science ®Google Scholar
• Lee YK, Ho PS, Low CS, et al. Permanent colonization by Lactobacillus casei is hindered by the low rate of cell division in mouse gut. Appl Environ Microbiol. 2004;70:670–674.
   PubMed Web of Science ®Google Scholar
• Uzal FA, Freedman JC, Shrestha A, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9:361–377.
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Parreira V, Sharif S, et al. Oral immunization of broiler chickens against necrotic enteritis with an attenuated Salmonella vaccine vector expressing Clostridium perfringens antigens. Vaccine. 2008;26:4194–4203.
   PubMed Web of Science ®Google Scholar
• Kulkarni R, Parreira V, Jiang YF, et al. A live oral recombinant Salmonella enterica serovar Typhimurium vaccine expressing Clostridium perfringens antigens confers protection against necrotic enteritis in broiler chickens. Clin Vaccine Immunol. 2010;17:205–214.
   PubMed Web of Science ®Google Scholar
• Zekarias B, Mo H, Curtiss R. Recombinant attenuated Salmonella enterica serovars Typhimurium expressing the carboxy-terminal domain of alpha toxin from Clostridium perfringens induces protective responses against necrotic enteritis in chickens. Clin Vaccine Immunol. 2008;15:805–816.
   PubMed Web of Science ®Google Scholar
• Wang M, Gao Z, Zhang Y, et al. Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option. Appl Microbiol Biotechnol. 2016;100:5691–5701.
   PubMed Web of Science ®Google Scholar
• Hoang VV, Ochi T, Kurata K, et al. Nisin-induced expression of recombinant T cell epitopes of major Japanese cedar pollen allergens in Lactococcus lactis. Appl Microbiol Biotechnol. 2018;102:261–268.
   PubMed Web of Science ®Google Scholar
• Alimolaei M, Golchin M, Daneshvar H. Oral immunization of mice against Clostridium perfringens epsilon toxin with a Lactobacillus casei vector vaccine expressing epsilon toxoid. Infect Genet Evol. 2016;40:282–287.
   PubMed Web of Science ®Google Scholar
• Alimolaei M, Golchin M, Ezatkhah M. Orally administered recombinant Lactobacillus casei vector vaccine expressing β-toxoid of Clostridium perfringens that induced protective immunity responses. Res Vet Sci. 2017;115:332–339.
   PubMed Web of Science ®Google Scholar